Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Klinik Indonesia JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) JSFK (Jurnal Sains Farmasi & Klinis) Keluwih: Jurnal Kesehatan dan Kedokteran Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan
Bobby Presley, Bobby
1) Departemen Farmasi Klinis Dan Komunitas, Faculty Of Pharmacy, University Of Surabaya 2) Pusat Informasi Obat Dan Layanan Kefarmasian (PIOLK), Faculty Of Pharmacy, University Of Surabaya
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 10 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 10 Documents
Search

 1 
Pencegahan Penyakit Kardiovaskular pada Pasien Diabetes Melitus Rawat Jalan: Fokus pada Penggunaan Antiplatelet, Statin dan Antihipertensi yang Belum Rasional Lie, Putri G. C. E.; Irawati, Sylvi; Presley, Bobby
Indonesian Journal of Clinical Pharmacy Vol 5, No 3 (2016)
Publisher : Indonesian Journal of Clinical Pharmacy

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (313.362 KB) | DOI: 10.15416/ijcp.2016.5.3.169

Abstract

  Komplikasi penyakit kardiovaskular merupakan penyebab utama morbiditas dan mortalitas pada pasien diabetes melitus (DM) sekaligus dapat menambah beban biaya bagi pasien maupun negara dalam era Jaminan Kesehatan Nasional (JKN). Sebagai salah satu upaya untuk mencegah dan mengurangi risiko tersebut, American Diabetes Associaton (ADA) merekomendasikan pemberian statin, antiplatelet, dan antihipertensi pada pasien DM. Penelitian ini bertujuan untuk melihat profil penggunaan obat untuk pencegahan penyakit kardiovaskular pada pasien DM rawat jalan. Penelitian ini bersifat non-eksperimental dan cross-sectional, dilakukan terhadap 100 pasien DM rawat jalan di sebuah rumah sakit di Surabaya selama periode November–Desember 2014. Hasil penelitian menunjukkan dari 100 pasien yang memenuhi kriteria penggunaan statin, hanya 25 pasien DM yang menggunakan statin. Sebanyak 23 (30,67%) pasien mendapatkan antiplatelet dari total 75 pasien DM yang memenuhi kriteria penggunaan antiplatelet. Antihipertensi ditemukan digunakan pada 42 pasien (87,50%) dari total 48 pasien DM dengan hipertensi, namun tidak semua pasien menggunakan angiotensin-converting enzyme inhibitors (ACEIs) atau angiotensin-receptor blockers (ARBs) sebagai pilihan terapi seperti yang direkomendasikan oleh berbagai pedoman terapi. Dengan demikian, secara keseluruhan penggunaan obat pencegahan penyakit kardiovaskular pada pasien DM masih belum optimal. Penelitian lebih lanjut diperlukan untuk mengidentifikasi faktor-faktor yang membatasi penggunaan obat pencegahan primer maupun sekunder penyakit kardiovaskular pada pasien DM.Kata kunci: Antihipertensi, antiplatelet, diabetes melitus, pencegahan kardiovaskular, statin Prevention of Cardiovascular Disease in Diabetes Mellitus Outpatient: Focusing on Antiplatelet, Statins and Irrational Antihypertensive Drug Use Cardiovascular disease complication is a major cause of morbidity and mortality in diabetes mellitus (DM) patients and all at once is an addition to economic burden to both the patient and government in the era of universal coverage (UC). As one of strategies to prevent and reduce the risk of cardiovascular disease complication, American Diabetes Associaton (ADA) recommends the use of statins, antiplatelet, dan antihipertensive agents in DM patients. This study aimed to describe the profile of cardiovascular disease preventive drugs used in DM outpatients. This was non-experimental and cross-sectional study included 100 DM outpatients during the period of November–December 2014. This study found that only 25 out of 100 patients who met-statin criteria were on statins. Antiplatelet agents were only prescribed in 23 (30.67%) out of 75 DM patients who met criteria. Antihypertensive agents were used in 42 (87.50%) out of 48 DM patients who were hypertensive, however angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-converting blockers (ARBs) were not used as an agent of choice as recommended by various guidelines. Overall, the use of cardiovascular disease preventive drugs in DM patients has yet to be optimal. Further research was needed to identify factors which confine the use of cardiovascular disease primary and secondary preventive drugs in DM patients.Keywords: Antihypertensive, antiplatelet, cardiovascular prevention, diabetes mellitus, statins
Pencegahan Penyakit Kardiovaskular pada Pasien Diabetes Melitus Rawat Jalan: Fokus pada Penggunaan Antiplatelet, Statin dan Antihipertensi yang Belum Rasional Putri G. C. E. Lie; Sylvi Irawati; Bobby Presley
Indonesian Journal of Clinical Pharmacy Vol 5, No 3 (2016)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (311.946 KB) | DOI: 10.15416/ijcp.2016.5.3.169

Abstract

  Komplikasi penyakit kardiovaskular merupakan penyebab utama morbiditas dan mortalitas pada pasien diabetes melitus (DM) sekaligus dapat menambah beban biaya bagi pasien maupun negara dalam era Jaminan Kesehatan Nasional (JKN). Sebagai salah satu upaya untuk mencegah dan mengurangi risiko tersebut, American Diabetes Associaton (ADA) merekomendasikan pemberian statin, antiplatelet, dan antihipertensi pada pasien DM. Penelitian ini bertujuan untuk melihat profil penggunaan obat untuk pencegahan penyakit kardiovaskular pada pasien DM rawat jalan. Penelitian ini bersifat non-eksperimental dan cross-sectional, dilakukan terhadap 100 pasien DM rawat jalan di sebuah rumah sakit di Surabaya selama periode November–Desember 2014. Hasil penelitian menunjukkan dari 100 pasien yang memenuhi kriteria penggunaan statin, hanya 25 pasien DM yang menggunakan statin. Sebanyak 23 (30,67%) pasien mendapatkan antiplatelet dari total 75 pasien DM yang memenuhi kriteria penggunaan antiplatelet. Antihipertensi ditemukan digunakan pada 42 pasien (87,50%) dari total 48 pasien DM dengan hipertensi, namun tidak semua pasien menggunakan angiotensin-converting enzyme inhibitors (ACEIs) atau angiotensin-receptor blockers (ARBs) sebagai pilihan terapi seperti yang direkomendasikan oleh berbagai pedoman terapi. Dengan demikian, secara keseluruhan penggunaan obat pencegahan penyakit kardiovaskular pada pasien DM masih belum optimal. Penelitian lebih lanjut diperlukan untuk mengidentifikasi faktor-faktor yang membatasi penggunaan obat pencegahan primer maupun sekunder penyakit kardiovaskular pada pasien DM.Kata kunci: Antihipertensi, antiplatelet, diabetes melitus, pencegahan kardiovaskular, statin Prevention of Cardiovascular Disease in Diabetes Mellitus Outpatient: Focusing on Antiplatelet, Statins and Irrational Antihypertensive Drug Use Cardiovascular disease complication is a major cause of morbidity and mortality in diabetes mellitus (DM) patients and all at once is an addition to economic burden to both the patient and government in the era of universal coverage (UC). As one of strategies to prevent and reduce the risk of cardiovascular disease complication, American Diabetes Associaton (ADA) recommends the use of statins, antiplatelet, dan antihipertensive agents in DM patients. This study aimed to describe the profile of cardiovascular disease preventive drugs used in DM outpatients. This was non-experimental and cross-sectional study included 100 DM outpatients during the period of November–December 2014. This study found that only 25 out of 100 patients who met-statin criteria were on statins. Antiplatelet agents were only prescribed in 23 (30.67%) out of 75 DM patients who met criteria. Antihypertensive agents were used in 42 (87.50%) out of 48 DM patients who were hypertensive, however angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-converting blockers (ARBs) were not used as an agent of choice as recommended by various guidelines. Overall, the use of cardiovascular disease preventive drugs in DM patients has yet to be optimal. Further research was needed to identify factors which confine the use of cardiovascular disease primary and secondary preventive drugs in DM patients.Keywords: Antihypertensive, antiplatelet, cardiovascular prevention, diabetes mellitus, statins
Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif Adji P. Setiadi; Yosi I. Wibowo; Steven V. Halim; Cecilia Brata; Bobby Presley; Eko Setiawan
Indonesian Journal of Clinical Pharmacy Vol 9, No 1 (2020)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15416/ijcp.2020.9.1.70

Abstract

Kasus pneumonia yang disebabkan oleh severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yang disebut coronavirus diseases 2019 (COVID-19) oleh World Health Organization (WHO) merupakan sebuah tragedi dalam dunia kesehatan secara global. Tata laksana yang tepat dan cepat diharapkan dapat menyelamatkan nyawa pasien. Sampai tulisan ini dibuat, belum terdapat satu jenis obat yang secara resmi diizinkan penggunaannya untuk terapi COVID-19. Kajian literatur ini bertujuan untuk 1) memaparkan tata laksana pengobatan dan 2) mendaftar serta menjelaskan alternatif obat yang dapat digunakan untuk SARS-CoV-2. Proses penelusuran artikel dalam kajian pustaka ini dilakukan pada sebuah database, yakni PubMed dengan kombinasi kata kunci ((“corona virus”) OR (“covid-19”) OR (“SARS-CoV-2”)) AND ((“treatment”) OR (“therapy”)). Hasil kajian ini menunjukkan bahwa tata laksana pasien dengan COVID-19 dapat berbeda antar-setting dan negara dengan mempertimbangkan ketersediaan sumber daya, khususnya obat. Pedoman terapi WHO dan pedoman di Indonesia saat ini merekomendasikan supportive therapy untuk penanganan COVID-19, antara lain: terapi untuk gejala yang terjadi, pemberian oksigen, penggunaan antibiotik, terapi cairan, penggunaan vasopresor, dan tindakan medis (termasuk pemasangan ventilator) untuk menyelamatkan nyawa pasien. Belum terdapat obat khusus yang direkomendasikan untuk menekan replikasi SARS-CoV-2. Beberapa jenis obat yang potensial bermanfaat untuk SARS-CoV-2 antara lain: klorokuin atau hidroksiklorokuin, arbidol, ribavirin, favipiravir, lopinavir/ritonavir, remdesivir, oseltamivir, dan interferon. Namun sampai dengan tulisan ini dibuat, terdapat keterbatasan bukti penelitian dengan desain yang baik yang dapat digunakan untuk menarik kesimpulan terkait superioritas suatu jenis obat tertentu dibandingkan dengan alternatif yang lain. Dalam kondisi menunggu hasil penelitian dengan desain penelitian yang baik, penggunaan obat yang memiliki bukti efektivitas (walaupun belum baik) atau diduga efektif, perlu dioptimalkan untuk menyelamatkan nyawa pasien, khususnya mereka yang dalam kondisi parah.Kata kunci: COVID-19, tata laksana, terapi Therapeutic Management of Patients with COVID-19: A Narrative ReviewAbstractPneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO)—has been a global public health emergency. Timely and effective therapeutic strategies are of importance in saving patients’ lives. However up to now, there is no specific treatment approved for COVID-19. This review aimed 1) to describe the available therapeutic strategies, and 2) to explore options of medications that can be used to treat COVID-19. A search strategy using keywords ((“corona virus”) OR (“covid-19”) OR (“SARS-CoV-2”)) AND ((“treatment”) OR (“therapy”)) was conducted in PubMed database. The review showed that treatment strategies could be different between settings and/or countries considering the availability of resources, particularly medications. The current WHO as well as the Indonesian guidelines mainly recommended supportive therapy to treat COVID-19, including: symptomatic care, oxygen therapy, antibiotics, fluid therapy, vasopressors, and taking medical interventions (including the use of ventilator). Studies conducted so far indicated the potential benefits of some medications, including chloroquine/hydrochloroquine, arbidol, ribavirin, favipiravir, lopinavir/ritonavir, remdesivir, oseltamivir, and interferon; however, the evidences available have been limited and not strong enough to recommend any specific medication for COVID-19. While waiting for quality evidences, optimising the use of medications—reported to have some levels of effectiveness—could be the current best option to save patients, especially those who are critically ill.Keywords: COVID, medication, therapeutic management
Persepsi dan Kecenderungan Keterlibatan Apoteker di Apotek pada Proses Rekonsiliasi Obat Eko Setiawan; Sylvi Irawati; Bobby Presley; Susilo Ari Wardhani
Jurnal Sains Farmasi & Klinis Vol 2, No 1 (2015): J Sains Farm Klin 2(1), November 2015
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (363.371 KB) | DOI: 10.29208/jsfk.2015.2.1.55

Abstract

The objective of this study was to gain insight into the perception and the likelihood to practice medication reconciliation among pharmacists working at the apotek. Two guiding questions were given to each participant and participants were asked to write the answer on the paper. Thematic analysis was used to analyse the data. There were 31 pharmacists involved in this study. All of participants perceived that medication reconciliation was important to be implemented. Almost all of participants (i.e 30 from 31 pharmacists) clearly stated that they would like to implement medication reconciliation. And, there were 3 themes found as the main motivation factors in implementing the medication reconciliation. Pharmacists who were working at the apotek had a good perception about medication reconciliation and also showed the likelihood to implement medication reconciliation. Further research need to be conducted in order to explore the barriers in implementing medication reconciliation.
Pengaruh Pemberian Layanan Kefarmasian pada Penderita Pneumonia Komunitas Rawat Inap: A Small Randomized Single Blind Study Bobby Presley; I. Setiabudi; Lestiono Lestiono; Ediyono Ediyono
Jurnal Sains Farmasi & Klinis Vol 2, No 1 (2015): J Sains Farm Klin 2(1), November 2015
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (325.016 KB) | DOI: 10.29208/jsfk.2015.2.1.54

Abstract

Pneumonia, one of infectious diseases, becomes a major health care problem in Indonesia. The inappropriateness use of treatment can lead to greater unexpected health outcome and prolonged length of stay. A lot of research has proved that pharmacists, as a part of health care professionals, has important role in assuring patients to get the most optimal treatment benefit. The aim of this study is to identify the influence of pharmaceutical care intervention in reducing the length of stay of inpatients community acquired pneumonia. This experimental study involved 32 subjects with community acquired pneumonia hospitalized without any other infection between 18th August and 31st December 2010. Subjects were divided into two groups, i.e. intervention and control group, by simple random sampling technique. Intervention group received pharmaceutical care services i.e. drug related problems identification and solving based on Pharmaceutical Care Network Europe Classification and therapy guideline. Both group received hospital standard care. The primary outcome of this study was length of stay. All subjects were followed until 31 December 2010. Most of drug related problems identified in this study were classified as treatment effectiveness (intervention group 76.19% and control group 81.82%) and treatment cost (intervention group 23.81% and control group 18.18%). Inappropriate use of antibiotic was the main cause for this drug related problems based on the pneumonia guideline. Ceftriaxone and ciprofloxacin (28.21%) were the most inappropriate used antibiotics found in this study. The mean of length of stay between intervention (6 days) and control group (8 days) was significantly different (P<0.05). Pharmaceutical care intervention significantly improved the length of stay of inpatients community acquired pneumonia.
Analysis of Profile and Contributing Factors to Non-adherence towards Antibiotics Utilization Among Caregivers of Paediatric Patients I Komang Agus Bayu Krisnanta; Nani Parfati; Bobby Presley; Eko Setiawan
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 1
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.33730

Abstract

Non-adherence to antibiotic is considered as one of causes of antibiotic resistance. Caregiver plays a vital role to ensure that the paediatric patients adhere to the antibiotic treatment prescribed by physician. This study aimed to analyze the profile and factors contributing to non-adherence behavior among caregivers of pediatric patients. Caregivers of pediatric patients were recruited from one of private clinic in Surabaya. The percentage ratio of medication used to total prescribed medication was calculated to measure adherence, cut-off of 80% was used in this study to categorize adherence and non-adherence. Factors contributing to the non-adherence behavior was identified by intervewing the caregivers and the results was analysed based on Theory of planned behavior as a guide for mapping factors contributing to non-adherence. Twenty-seven out of a total of 38 caregivers (71.05%) categorized as non-adherence to the therapy. Several factors hindered adherence behavior identified in this study were: caregivers’ belief on adverse drug reaction, false belief on the health prognostic, false knowledge about antibiotic, time commitment of caregivers, forgetfulness, sharing medication among family member phenomenon, and type of medicine preparation. Prevalence of non-adherence behavior to antibiotic among community in Surabaya is relatively high and lack of knowledge does not always be the only reason behind it. Other factors that might influence medication non-adherence need to be considered to get better result, instead of only focusing on increasing patient’s knowledge. Further study is needed to identify the best and more effective intervention to improve adherence as preliminary mapping before establishing local or national scale policy.
Direct Medical Cost Analysis Among Coronary Heart Disease and Heart Failure Outpatients at One Hospital Nunik Dewi Kumalasari; Abdul Rahem; Bobby Presley; Eko Setiawan
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 9, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (623.317 KB) | DOI: 10.22146/jmpf.38170

Abstract

Long-term treatment of cardiovascular disease may give impact in a high burden of medical cost for the patient. A concern arises whether the health budget allocation prepared by the Indonesian Government through "Jaminan Kesehatan Nasional" program is enough to cover medical cost for the outpatient treatment. This study aims to calculate the direct medical cost of patients with coronary heart disease and heart failure and compare it with the Indonesian Case Base Groups (INA-CBGs) tariff. This is a prospective and observational study carried out in one of the public hospitals in East Java between February and April 2015. All data related to outpatients with coronary heart disease and heart failure were analysed. Direct medical cost analysis in this study calculated from a combination of cost of medication, health professional services, electrocardiography, emergency care services, and laboratory test component, then it was compared with INA-CBGs tariff from ICD 10. Total of 390 patients included were 387 patients with coronary heart disease (99.23%) and three (3) patients with heart failure (0.77%). Average direct medical cost for patients with coronary heart disease and heart failure were IDR 130.593,6 (range IDR 50.282 – IDR 385.911) and IDR 128.587 (range IDR 112.832 – IDR 140.103), respectively. Even though this study showed that budget allocation of INA-CBGs could cover the average direct medical cost of patients with both of diseases, some patients had a direct medical cost higher than the limit of INA-CBGs allocation. Therefore, an optimal interprofessional collaboration between physician and pharmacist needed to provide medical treatment based on patient needs and keep it within budget allocation range.
Profil Kerapuhan dan Masalah terkait Obat pada Kelompok Lanjut Usia di Panti Jompo Kota Surabaya Verlita Evelyn Susanto; Adji Prayitno Setiadi; Bobby Presley; Steven Victoria Halim; Eko Setiawan
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 9, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (638.489 KB) | DOI: 10.22146/jmpf.38869

Abstract

Frailty and drug related problems (DRPs) are common among elderly who lives in the nursing home. There is currently limited information available regarding the profile of frailty and DRPs among elderly living in the nursing homes in Indonesia. This project aims to describe the profile of frailty and DRPs among nursing home residents in Surabaya. This cross-sectional study was conducted in three nursing homes in Surabaya. Integrated Systematic Care for older People (ISCOPE) questionnaire was used to identify the frailty profile among participants. Beers Criteria, screening tool of older person’s prescriptions (STOPP), geriatric dosage handbook and drug interactions analysis and management were used as tools to identify and analyse drug related problems in this study. Several DRPs were identified in this study including inappropriate drug choices, drugs interaction, and inappropriate dose of drugs. In total, 68 elderly were recruited in this study and 41.18% of them were classified as frail older people. There was no drugs interaction with “clinical significance” being identified, however, inappropriate dose of drugs and potentially inappropriate drug choices were found in 58.82% and 19.12% of nursing home residents, respectively. Findings regarding the profile of frailty and DRPs among elderly may indicate the needs to implement an appropriate intervention strategic in order to optimize the use of medications among nursing homes-dwelling elderly people.
KETEPATAN REKOMENDASI PADA KASUS VIGNETTE SWAMEDIKASI SAKIT KEPALA OLEH APOTEKER DI APOTEK Amalia, Nurul; Wibowo, Yosi Irawati; Halim, Steven Victoria; Setiawan, Eko; Irawati, Sylvi; Presley, Bobby; Setiadi, Adji Prayitno; Brata, Cecilia
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan 2023: Webinar Nasional & Call For Paper
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v8i3.1677

Abstract

Headache is a symptom which people often self-medicate and community pharmacies are often places where self-medicating patients with headache obtain the medicines. Therefore, community pharmacists played an important role in providing appropriate advice for these patients. A cross-sectional study design was used. A questionnaire consisting of (1) pharmacy and pharmacists characteristics, and (2) two vignette cases of headache (tension headache and migraine due to an oral contraceptive) was developed. Data was collected using a structured interview with community pharmacists in an East Javan district. Data was analysed using content analysis. Appropriate recommendation was determined based on the literature and expert panel opinion. The total population was 81 community pharmacists. Of these, 47 agreed to participate. Of 47 participating pharmacists, 36 (77%) and 23 (49%) pharmacists provided appropriate advice in the case of tension headache and migraine due to the use of an oral contraceptive respectively. Appropriate recommendation provided by pharmacists varied according to the cases. Optimization of pharmacists’ recommendation in a case of headache requiring medical referral is needed.
Pharmacist Involvement to Prevent and Manage HIV/AIDS in Indonesia: A Systematic Review Firmansah, Moh.; Setiawan, Eko; Presley, Bobby; Christanti, Jene Vida; Irawati, Sylvi
Keluwih: Jurnal Kesehatan dan Kedokteran Vol. 5 No. 1 (2023): Keluwih: Jurnal Kesehatan dan Kedokteran (December)
Publisher : Direktorat Penerbitan dan Publikasi Ilmiah, Universitas Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24123/kesdok.V5i1.5815

Abstract

Abstract—Pharmacists’ involvement in the human immunodeficiency virus/acquired-immunodeficiency syndrome (HIV/AIDS) prevention and management program has been globally advocated. However, there is currently a lack of information on whether pharmacists’ roles in the program have been clearly articulated in the national policy records in countries with high scores on power distance and collectivism, such as Indonesia. This study aimed to explore the roles of pharmacists in the prevention and management of HIV/AIDS in Indonesia using a systematic review method. We systematically searched for relevant studies in three large medical databases (CINAHL, EMBASE, and PubMed) and for gray literature in both the Indonesian Pharmacist Association and the Ministry of Health websites, and the national regulation database. Only two studies gave a glimpse of pharmacists’ role in the prevention and management of patients with HIV/AIDS in Indonesia. However, activities conducted by pharmacists in each of these roles were not explicitly described. We found no official national policies mentioned the role of pharmacists in HIV/AIDS prevention and management. Since the practice of pharmacists is closely related to medications, including antiretroviral drugs, more research is needed to explore the role of pharmacists in the prevention and management of HIV/AIDS in a real-world context in Indonesia. Keywords: AIDS, HIV, pharmacist, indonesia Abstrak—Keterlibatan apoteker dalam program pencegahan dan tata laksana human immunodeficiency virus/acquired-immunodeficiency syndrome (HIV/AIDS) di dunia telah direkomendasikan. Akan tetapi, saat ini terdapat keterbatasan informasi mengenai apakah keberadaan peran apoteker dalam program tersebut telah dinyatakan dnegan jelas dalam dokumen kebijakan nasional di negara-negara yang memiliki skor tinggi pada power distance dan kolektivitas, seperti Indonesia. Penelitian ini bertujuan untuk menggali peran apoteker dalam pencegahan dan tata laksana HIV/AIDS di Indonesia menggunakan metode kajian sistematis. Secara sistematis, peneliti melakukan pencarian artikel penelitian terkait di tiga basis data medis yang besar (CINAHL, EMBASE, dan PubMed) dan pencarian gray literature di laman Ikatan Apoteker Indonesia dan Kementerian Kesehatan Republik Indonesia, serta di basis data peraturan nasional. Hanya dua penelitian yang memberikan secercah informasi mengenai peran apoteker dalam pencegahan dan tata laksana pasien dengan HIV/AIDS di Indonesia. Namun demikian, aktivitas spesifik yang dilakukan oleh apoteker tidak secara eksplisit digambarkan lebih lanjut. Peneliti tidak menemukan dokumen kebijakan nasional yang menyebutkan peran apoteker dalam pencegahan dan tata laksana HIV/AIDS. Oleh karena praktik kefarmasian berhubungan erat dengan obat, termasuk obat-obat antiretrovirus, maka dibutuhkan lebih banyak penelitian untuk menggali peran apoteker dalam pencegahan dan tata laksana HIV/AIDS pada konteks dunia-nyata di Indonesia. Kata kunci: AIDS, HIV, apoteker,indonesia
Co-Authors Abdul Rahem Abdul Rahem, Abdul Adji P. Setiadi Adji Prayitno Setiadi Brata, Cecilia Cecilia Brata Christanti, Jene Vida Ediyono Ediyono Eko Setiawan Eko Setiawan Eko Setiawan Eko Setiawan Eko Setiawan Firmansah, Moh. Halim, Steven Victoria I Komang Agus Bayu Krisnanta I. Setiabudi Krisnanta, I Komang Agus Bayu Kumalasari, Nunik Dewi Lestiono Lestiono Lie, Putri G. C. E. Nani Parfati Nani Parfati, Nani Nunik Dewi Kumalasari Nurul Amalia Putri G. C. E. Lie Setiadi, Adji Prayitno Setiawan, Eko Steven V. Halim Susanto, Verlita Evelyn Susilo Ari Wardhani Sylvi Irawati Verlita Evelyn Susanto Wibowo, Yosi Irawati Yosi I. Wibowo